Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05187364 · ClinicalTrials.gov registry record · NA
BioWare for AUD and PTSD
A NA study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT05187364 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 4 participants.
The verdict
NCT05187364, a NA study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
This study examines the ability of an innovative telehealth technology system to enhance Concurrent Treatment of PTSD and Substance Use Disorders using Prolonged Exposure (COPE) talk-therapy for individuals with posttraumatic stress disorder (PTSD) and alcohol use disorder.
Interventions
- BEHAVIORAL COPE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2022-05-05 |
| Est. Completion | 2023-02-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05187364
The ClinicalTrials.gov registry entry for NCT05187364 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which COPE is the first listed.
NCT05187364 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05187364 about?
NCT05187364 is a clinical study titled "BioWare for AUD and PTSD". This study examines the ability of an innovative telehealth technology system to enhance Concurrent Treatment of PTSD and Substance Use Disorders using Prolonged Exposure (COPE) talk-therapy for individuals with posttraumatic stress disorder (PTSD) and alcohol use disorder.
What is the current status of trial NCT05187364?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2022-05-05. Estimated completion is 2023-02-20.
What interventions are being tested in trial NCT05187364?
The interventions under investigation include: COPE (BEHAVIORAL).
Who is sponsoring clinical trial NCT05187364?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.